393 related articles for article (PubMed ID: 28458337)
1. Outcomes analysis of surgical and medical treatments for patients with primary aldosteronism.
Park KS; Kim JH; Yang YS; Hong AR; Lee DH; Moon MK; Choi SH; Shin CS; Kim SW; Kim SY
Endocr J; 2017 Jun; 64(6):623-632. PubMed ID: 28458337
[TBL] [Abstract][Full Text] [Related]
2. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
[TBL] [Abstract][Full Text] [Related]
3. Renal Outcomes in Medically and Surgically Treated Primary Aldosteronism.
Hundemer GL; Curhan GC; Yozamp N; Wang M; Vaidya A
Hypertension; 2018 Sep; 72(3):658-666. PubMed ID: 29987110
[TBL] [Abstract][Full Text] [Related]
4. Hyperkalemia in both surgically and medically treated patients with primary aldosteronism.
Wada N; Shibayama Y; Umakoshi H; Ichijo T; Fujii Y; Kamemura K; Kai T; Sakamoto R; Ogo A; Matsuda Y; Fukuoka T; Tsuiki M; Suzuki T; Naruse M
J Hum Hypertens; 2017 Oct; 31(10):627-632. PubMed ID: 28540931
[TBL] [Abstract][Full Text] [Related]
5. Predictors of decreasing glomerular filtration rate and prevalence of chronic kidney disease after treatment of primary aldosteronism: renal outcome of 213 cases.
Iwakura Y; Morimoto R; Kudo M; Ono Y; Takase K; Seiji K; Arai Y; Nakamura Y; Sasano H; Ito S; Satoh F
J Clin Endocrinol Metab; 2014 May; 99(5):1593-8. PubMed ID: 24285678
[TBL] [Abstract][Full Text] [Related]
6. Eplerenone improves carotid intima-media thickness (IMT) in patients with primary aldosteronism.
Matsuda Y; Kawate H; Matsuzaki C; Sakamoto R; Shibue K; Ohnaka K; Anzai K; Nomura M; Takayanagi R
Endocr J; 2016; 63(3):249-55. PubMed ID: 26727302
[TBL] [Abstract][Full Text] [Related]
7. Clinical and biochemical outcomes after adrenalectomy and medical treatment in patients with unilateral primary aldosteronism.
Katabami T; Fukuda H; Tsukiyama H; Tanaka Y; Takeda Y; Kurihara I; Ito H; Tsuiki M; Ichijo T; Wada N; Shibayama Y; Yoshimoto T; Ogawa Y; Kawashima J; Sone M; Inagaki N; Takahashi K; Fujita M; Watanabe M; Matsuda Y; Kobayashi H; Shibata H; Kamemura K; Otsuki M; Fujii Y; Yamamoto K; Ogo A; Yanase T; Suzuki T; Naruse M;
J Hypertens; 2019 Jul; 37(7):1513-1520. PubMed ID: 31145370
[TBL] [Abstract][Full Text] [Related]
8. Clinical risk factors of postoperative hyperkalemia after adrenalectomy in patients with aldosterone-producing adenoma.
Park KS; Kim JH; Ku EJ; Hong AR; Moon MK; Choi SH; Shin CS; Kim SW; Kim SY
Eur J Endocrinol; 2015 Jun; 172(6):725-31. PubMed ID: 25766046
[TBL] [Abstract][Full Text] [Related]
9. Incidence and factors of post-adrenalectomy hyperkalemia in patients with aldosterone producing adenoma.
Chiang WF; Cheng CJ; Wu ST; Sun GH; Lin MY; Sung CC; Lin SH
Clin Chim Acta; 2013 Sep; 424():114-8. PubMed ID: 23727469
[TBL] [Abstract][Full Text] [Related]
10. Endocrine and hypertensive disorders of potassium regulation: primary aldosteronism.
Weiner ID
Semin Nephrol; 2013 May; 33(3):265-76. PubMed ID: 23953804
[TBL] [Abstract][Full Text] [Related]
11. Progress in primary aldosteronism. Mineralocorticoid antagonist treatment for aldosterone-producing adenoma.
Amar L; Lorthioir A; Azizi M; Plouin PF
Eur J Endocrinol; 2015 Mar; 172(3):R125-9. PubMed ID: 25315875
[TBL] [Abstract][Full Text] [Related]
12. Association Between Acute Fall in Estimated Glomerular Filtration Rate After Treatment for Primary Aldosteronism and Long-Term Decline in Renal Function.
Kobayashi H; Abe M; Nakamura Y; Takahashi K; Fujita M; Takeda Y; Yoneda T; Kurihara I; Itoh H; Tsuiki M; Wada N; Ichijo T; Katabami T; Ogawa Y; Kawashima J; Yoshimoto T; Sone M; Inagaki N; Watanabe M; Kamemura K; Matsuda Y; Izawa S; Tanabe M; Tanabe A; Suzuki T; Naruse M;
Hypertension; 2019 Sep; 74(3):630-638. PubMed ID: 31327258
[TBL] [Abstract][Full Text] [Related]
13. Medical or surgical therapy for primary aldosteronism: post-treatment follow-up as a surrogate measure of comparative outcomes.
Kline GA; Pasieka JL; Harvey A; So B; Dias VC
Ann Surg Oncol; 2013 Jul; 20(7):2274-8. PubMed ID: 23504117
[TBL] [Abstract][Full Text] [Related]
14. Contralateral suppression of aldosterone at adrenal venous sampling predicts hyperkalemia following adrenalectomy for primary aldosteronism.
Shariq OA; Bancos I; Cronin PA; Farley DR; Richards ML; Thompson GB; Young WF; McKenzie TJ
Surgery; 2018 Jan; 163(1):183-190. PubMed ID: 29129366
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of Alternative Therapy with Hydrocortisone in the Postoperative Management of Severe Primary Aldosteronism.
Asakawa M; Takagi N; Hamada D; Yamasaki Y; Takaku Y; Kawada M; Murata T; Katsuta H
Intern Med; 2023 Oct; 62(20):2981-2988. PubMed ID: 36858518
[TBL] [Abstract][Full Text] [Related]
16. Mineralocorticoid Receptor Antagonists and Clinical Outcomes in Primary Aldosteronism: As Good as Surgery?
Sechi LA; Colussi GL; Novello M; Uzzau A; Catena C
Horm Metab Res; 2015 Dec; 47(13):1000-6. PubMed ID: 26667803
[TBL] [Abstract][Full Text] [Related]
17. SFE/SFHTA/AFCE consensus on primary aldosteronism, part 6: Adrenal surgery.
Steichen O; Amar L; Chaffanjon P; Kraimps JL; Ménégaux F; Zinzindohoue F
Ann Endocrinol (Paris); 2016 Jul; 77(3):220-5. PubMed ID: 27297451
[TBL] [Abstract][Full Text] [Related]
18. [Chronic kidney disease after adrenalectomy in a patient with primary aldosteronism].
An WC; Yan HX; Deng ZZ; Chen F; Ou XH; Jin HX; Huang W
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 53(6):1201-1204. PubMed ID: 34916706
[TBL] [Abstract][Full Text] [Related]
19. [Hyperaldosteronism persisting after subtotal adrenalectomy].
Fendrich V; Ramaswamy A; Nies C
Chirurg; 2003 May; 74(5):473-7. PubMed ID: 12748796
[TBL] [Abstract][Full Text] [Related]
20. Development of novel nomograms to predict renal functional outcomes after laparoscopic adrenalectomy in patients with primary aldosteronism.
Utsumi T; Kamiya N; Kaga M; Endo T; Yano M; Kamijima S; Kawamura K; Imamoto T; Ichikawa T; Suzuki H
World J Urol; 2017 Oct; 35(10):1577-1583. PubMed ID: 28401356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
